Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Theravance Biopharma)"
Count: 74
Selected: 0
| NCT ID | Title |
|---|
| NCT05696717 | Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy | ||
| NCT05165485 | Phase 4 COPD and Suboptimal Inspiratory Flow Rate | ||
| NCT05091723 | TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation | ||
| NCT04688632 | Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects | ||
| NCT04681079 | Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19 | ||
| NCT04589260 | TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis | ||
| NCT04587713 | Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects | ||
| NCT04402866 | TD-0903 for ALI Associated With COVID-19 | ||
| NCT04350736 | First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 | ||
| NCT04200573 | Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855 | ||
| NCT04150341 | Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response | ||
| NCT04095793 | Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure | ||
| NCT04044339 | Single and Multiple Ascending Dose, First-in- Human Study in Healthy Subjects | ||
| NCT03920254 | TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study | ||
| NCT03829657 | Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure | ||
| NCT03758443 | Efficacy & Safety of TD-1473 in Ulcerative Colitis | ||
| NCT03750565 | Multiple Dose Ethnobridging PK Study in Healthy Subjects | ||
| NCT03750552 | Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure | ||
| NCT03652038 | Single and Multiple Ascending Dose Study of TD-8236 by Inhalation | ||
| NCT03635112 | Efficacy and Safety of TD-1473 in Crohn's Disease | ||
| NCT03555617 | Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study | ||
| NCT03432793 | Drug-Drug Interaction (DDI) Study for TD-9855 | ||
| NCT03408470 | TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects | ||
| NCT03103412 | TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC) | ||
| NCT02954263 | Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects | ||
| NCT02903095 | Single Ascending Dose Study of TD-1439 in Healthy Subjects | ||
| NCT02818686 | TD-1473 for Active Ulcerative Colitis (UC) | ||
| NCT02709928 | Multiple Ascending Dose Study of TD-0714 in Healthy and Elderly Subjects | ||
| NCT02705755 | TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) | ||
| NCT02663089 | A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects | ||
| NCT02657122 | SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects | ||
| NCT02639078 | Single Ascending Dose Study of TD-0714 in Healthy Subjects | ||
| NCT02267525 | The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study | ||
| NCT02116543 | TD-6450 MAD Study in HCV Infected Subjects | ||
| NCT02022306 | TD-6450 SAD and MAD in Healthy Subjects | ||
| NCT01949103 | TD-1607 MAD Study in Healthy Subjects | ||
| NCT01924143 | TD-9855 Mass Balance Study | ||
| NCT01791049 | TD-1607 SAD Study in Healthy Subjects | ||
| NCT01718938 | Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis | ||
| NCT01702194 | TD-1211 IV/Oral Mass Balance Study | ||
| NCT01693692 | Phase 2 Study of TD-9855 to Treat Fibromyalgia | ||
| NCT01655771 | TD-1211 Single-Dose Study in Elderly and Young Healthy Subjects | ||
| NCT01644240 | A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects | ||
| NCT01568411 | A Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD-1211 | ||
| NCT01467726 | Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects | ||
| NCT01459926 | A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation | ||
| NCT01458340 | A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) | ||
| NCT01401985 | A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC) | ||
| NCT01333540 | A Study to Assess the Safety, Tolerability and Clinical Activity of TD-1211 in Patients With Opioid-Induced Constipation | ||
| NCT01040637 | A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation |
